Company / Total Assets
Oncology Institute, Inc. Total Assets History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$164.7M
FY2025
5-year range
$164.7M / $261.7M
FY2021-FY2025
Trend
-4.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets has declined for 3 consecutive years, from $262M in FY2022 to $165M in FY2025.
Based on SEC 10-K filings.
$165M in FY2025 with a 3-year CAGR of -14.3%.
Declined from $209M to $165M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -14.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Oncology Institute, Inc.'s total assets has declined for 3 consecutive years.
- 3-year CAGR of -14.3%, indicating a declining trend.
- In FY2025, total assets decreased 4.7% year-over-year.
- Peak total assets was recorded in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $164.7M | -4.7% |
| FY2024 | $172.7M | -17.5% |
| FY2023 | $209.2M | -20.0% |
| FY2022 | $261.7M | +28.6% |
| FY2021 | $203.4M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026